Cargando…
Microfluidic chip enables single-cell measurement for multidrug resistance in triple-negative breast cancer cells
Aims: Triple-negative breast cancer patients are commonly treated with combination chemotherapy. Nonetheless, outcomes remain substandard with relapses being of a frequent occurrence. Among the several mechanisms that result in treatment failure, multidrug resistance, which is mediated by ATP-bindin...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
OAE Publishing Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992477/ https://www.ncbi.nlm.nih.gov/pubmed/35582454 http://dx.doi.org/10.20517/cdr.2019.77 |